$ENTA
ENANTA PHARMACEUTICALS INC

2019 Q3 Form 10-Q Financial Statement

#000156459019031249 Filed on August 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $51.31M $44.37M $57.26M
YoY Change -23.65% -22.52% 662.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.160M $6.150M $6.140M
YoY Change 5.66% 0.16% 17.4%
% of Gross Profit
Research & Development $38.72M $34.46M $28.49M
YoY Change 43.83% 20.97% 84.86%
% of Gross Profit
Depreciation & Amortization $890.0K $890.0K $660.0K
YoY Change 34.85% 34.85% 20.0%
% of Gross Profit
Operating Expenses $44.88M $40.61M $28.49M
YoY Change 37.04% 42.56% 38.02%
Operating Profit $3.755M $22.64M
YoY Change -83.41%
Interest Expense $2.270M $2.420M $1.328M
YoY Change 58.74% 82.23% 121.33%
% of Operating Profit 64.45% 5.87%
Other Income/Expense, Net $2.274M $2.415M $1.338M
YoY Change 59.13% 80.49% 123.0%
Pretax Income $8.710M $6.170M $23.98M
YoY Change -75.72% -74.27% -291.36%
Income Tax -$486.0K -$866.0K $3.690M
% Of Pretax Income -5.58% -14.04% 15.39%
Net Earnings $9.191M $7.036M $20.29M
YoY Change -66.48% -65.32% -340.78%
Net Earnings / Revenue 17.91% 15.86% 35.43%
Basic Earnings Per Share $0.47 $0.36 $1.05
Diluted Earnings Per Share $0.44 $0.33 $0.97
COMMON SHARES
Basic Shares Outstanding 19.68M 19.67M 19.30M
Diluted Shares Outstanding 21.11M 21.02M

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $335.2M $389.2M $273.2M
YoY Change 8.59% 42.48% 42.29%
Cash & Equivalents $51.23M $94.21M $43.09M
Short-Term Investments $284.0M $295.0M $230.8M
Other Short-Term Assets $15.30M $17.60M $9.400M
YoY Change 240.0% 87.23% 42.42%
Inventory
Prepaid Expenses
Receivables $51.31M $44.37M $57.30M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $401.8M $451.3M $339.9M
YoY Change 5.64% 32.76% 64.92%
LONG-TERM ASSETS
Property, Plant & Equipment $10.93M $11.37M $8.400M
YoY Change 30.49% 35.39% 3.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $65.00M $0.00 $22.30M
YoY Change 296.34% -100.0% -48.5%
Other Assets $92.00K $92.00K $8.500M
YoY Change 0.0% -98.92% -53.55%
Total Long-Term Assets $87.98M $22.22M $39.20M
YoY Change 160.01% -43.31% -43.76%
TOTAL ASSETS
Total Short-Term Assets $401.8M $451.3M $339.9M
Total Long-Term Assets $87.98M $22.22M $39.20M
Total Assets $489.8M $473.5M $379.1M
YoY Change 18.25% 24.9% 37.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.689M $6.504M $4.900M
YoY Change 40.97% 32.73% -10.91%
Accrued Expenses $15.92M $14.00M $9.100M
YoY Change 60.94% 53.81% 62.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.61M $20.50M $14.00M
YoY Change 41.09% 46.44% 26.13%
LONG-TERM LIABILITIES
Long-Term Debt $1.800M $1.900M $1.800M
YoY Change -5.26% 5.56% 200.0%
Other Long-Term Liabilities $3.100M $3.258M $2.300M
YoY Change 7.08% 41.65% -30.3%
Total Long-Term Liabilities $3.100M $3.258M $4.100M
YoY Change 7.08% -20.54% 5.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.61M $20.50M $14.00M
Total Long-Term Liabilities $3.100M $3.258M $4.100M
Total Liabilities $27.34M $25.39M $18.20M
YoY Change 33.04% 39.49% 21.33%
SHAREHOLDERS EQUITY
Retained Earnings $163.7M $154.5M
YoY Change 39.52%
Common Stock $298.6M $293.4M
YoY Change 7.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $462.5M $448.1M $360.9M
YoY Change
Total Liabilities & Shareholders Equity $489.8M $473.5M $379.1M
YoY Change 18.25% 24.9% 37.45%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $9.191M $7.036M $20.29M
YoY Change -66.48% -65.32% -340.78%
Depreciation, Depletion And Amortization $890.0K $890.0K $660.0K
YoY Change 34.85% 34.85% 20.0%
Cash From Operating Activities $8.550M $2.530M $4.050M
YoY Change -69.83% -37.53% -184.55%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K -$2.230M -$1.100M
YoY Change -51.61% 102.73% 48.65%
Acquisitions
YoY Change
Other Investing Activities -$51.91M -$12.62M -$30.37M
YoY Change 609.15% -58.45% -461.55%
Cash From Investing Activities -$52.20M -$14.85M -$31.46M
YoY Change 556.6% -52.8% -510.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 680.0K 490.0K 2.970M
YoY Change -33.98% -83.5% 1463.16%
NET CHANGE
Cash From Operating Activities 8.550M 2.530M 4.050M
Cash From Investing Activities -52.20M -14.85M -31.46M
Cash From Financing Activities 680.0K 490.0K 2.970M
Net Change In Cash -42.97M -11.83M -24.44M
YoY Change -300.61% -51.6% -898.69%
FREE CASH FLOW
Cash From Operating Activities $8.550M $2.530M $4.050M
Capital Expenditures -$300.0K -$2.230M -$1.100M
Free Cash Flow $8.850M $4.760M $5.150M
YoY Change -69.44% -7.57% -227.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
Massachusetts
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
043205099
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Arsenal Street
us-gaap Operating Income Loss
OperatingIncomeLoss
30307000
us-gaap Costs And Expenses
CostsAndExpenses
85544000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22640000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M25D
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20487000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-483000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
561000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
76000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
179000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37753000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-483000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44053000
CY2017Q4 enta Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
436000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
360901000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
7036000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
317579000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1770000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
043205099
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
295042000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
244828000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44367000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67205000
dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17647000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4454000
CY2019Q2 us-gaap Assets
Assets
473484000
CY2018Q3 us-gaap Assets
Assets
414227000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6504000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4745000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13997000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
451262000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M25D
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity File Number
EntityFileNumber
001-35839
dei Local Phone Number
LocalPhoneNumber
607-0800
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19681609
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94206000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63902000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
380389000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
16389000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11373000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8374000
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
10149000
CY2018Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
8375000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
608000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
608000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9892000
CY2018Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1388000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20501000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16025000
CY2019Q2 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1628000
CY2018Q3 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1628000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3258000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2895000
CY2019Q2 us-gaap Liabilities
Liabilities
25387000
CY2018Q3 us-gaap Liabilities
Liabilities
20548000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19682000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19682000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19395000
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19395000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
197000
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
194000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20083000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17611000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
40612000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
34622000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4025000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
199000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
393679000
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1161000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
293188000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
276526000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
163000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-398000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
154549000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
117357000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
448097000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
393679000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
473484000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
414227000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153884000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139420000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28487000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
103494000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67933000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6151000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6135000
us-gaap Costs And Expenses
CostsAndExpenses
123577000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3755000
us-gaap Operating Income Loss
OperatingIncomeLoss
53876000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
7036000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19673000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21105000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
20288000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-159000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
301676000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
561000
us-gaap Net Income Loss
NetIncomeLoss
37192000
us-gaap Net Income Loss
NetIncomeLoss
44536000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
199000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
175000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
199000
CY2017Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4120000
CY2019Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1628000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
41000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-37000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
84000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4164000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
175000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
7036000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
26011000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
426835000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
448097000
us-gaap Profit Loss
ProfitLoss
37192000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4466000
CY2019Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-4188000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4707000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
245000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
4145000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
436210000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
512000
us-gaap Profit Loss
ProfitLoss
44536000
us-gaap Share Based Compensation
ShareBasedCompensation
14714000
us-gaap Share Based Compensation
ShareBasedCompensation
11735000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2367000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1857000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1953000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2353000
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
274000
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
297000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3489000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
238000
CY2017Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-346000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
11693000
CY2018Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1756000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3590000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-336000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
12555000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
333402000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2987000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
20288000
CY2018Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5843000
CY2018Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
141000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-22838000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
46648000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13193000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5868000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1639000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1446000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3956000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1150000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1388000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9298000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
427000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
276000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62873000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
879000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
353382000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
179076000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
338000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1865000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
324047000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
153981000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
158000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
68000
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
us-gaap Year Founded
YearFounded
1995
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5121000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2358000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34456000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27453000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6139000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5192000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4188000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1757000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
64000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
59000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1887000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3376000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30304000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23198000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
64510000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66283000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94814000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43085000
us-gaap Income Taxes Paid
IncomeTaxesPaid
12615000
us-gaap Income Taxes Paid
IncomeTaxesPaid
21404000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, <span style="Background-color:#FFFFFF;">management’s judgments with respect to its revenue arrangements; valuation of stock-based awards; the accrual of research and development </span></p> <p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">expenses, and the accounting for income taxes, including uncertain tax positions and the valuation of net deferred tax assets. </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company’s estimates.</span></p>
CY2019Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
383117000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
593000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13997000
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
323227000
CY2018Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1628000
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
294876000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
223000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
57000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
295042000
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
261791000
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
575000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
261217000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
16389000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0
CY2019Q2 enta Accrued Preclinical And Clinical Expenses Current
AccruedPreclinicalAndClinicalExpensesCurrent
5792000
CY2018Q3 enta Accrued Preclinical And Clinical Expenses Current
AccruedPreclinicalAndClinicalExpensesCurrent
3617000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2902000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3274000
CY2019Q2 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
3653000
CY2018Q3 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
1901000
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
962000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
507000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
688000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9892000
CY2019Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1865000
CY2018Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1792000
CY2019Q2 us-gaap Accrued Rent Noncurrent
AccruedRentNoncurrent
923000
CY2018Q3 us-gaap Accrued Rent Noncurrent
AccruedRentNoncurrent
593000
CY2019Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
224000
CY2018Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
293000
CY2019Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
246000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2981000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
115641000
CY2018Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
217000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3258000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2895000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2624000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.65
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
129115000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
614000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
82.97
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
209000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
29.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
48000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
67.51
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2981000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.22
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
46.22
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
115641000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1852000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
35.92
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
90091000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3690000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4164000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4025000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14714000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11735000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4164000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4025000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14714000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11735000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
42275000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
7036000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
20288000
us-gaap Net Income Loss
NetIncomeLoss
37192000
us-gaap Net Income Loss
NetIncomeLoss
44536000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19673000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19303000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19549000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19212000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
7036000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
20288000
us-gaap Net Income Loss
NetIncomeLoss
37192000
us-gaap Net Income Loss
NetIncomeLoss
44536000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19673000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19303000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19549000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19212000
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1432000
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1714000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1450000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1297000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21105000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21017000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20999000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20509000
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
830000
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
117000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
740000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-866000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-340000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12704000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.245
enta Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
3859000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1792000
enta Number Of Leases
NumberOfLeases
2
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1869000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1519000
CY2019Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
608000
CY2018Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
608000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
608000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
608000

Files In Submission

Name View Source Status
0001564590-19-031249-index-headers.html Edgar Link pending
0001564590-19-031249-index.html Edgar Link pending
0001564590-19-031249.txt Edgar Link pending
0001564590-19-031249-xbrl.zip Edgar Link pending
enta-10q_20190630.htm Edgar Link pending
enta-10q_20190630_htm.xml Edgar Link completed
enta-20190630.xsd Edgar Link pending
enta-20190630_cal.xml Edgar Link unprocessable
enta-20190630_def.xml Edgar Link unprocessable
enta-20190630_lab.xml Edgar Link unprocessable
enta-20190630_pre.xml Edgar Link unprocessable
enta-ex311_12.htm Edgar Link pending
enta-ex312_11.htm Edgar Link pending
enta-ex321_10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gf2fu0tmzn3e000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending